Abstract
Recombinant adenovirus (Ad)-mediated gene therapy is an exciting novel strategy incancer treatment. However, poor infection efficiency with coxsackievirus and adenovirusreceptor (CAR) down-regulated cancer cell lines is one of the major challenges for itspractical and extensive application. As an alternative method of viral gene delivery, anon-viral carrier using cationic materials could compensate for the limitation ofadenovirus. In our study, adenovectors were complexed with a new synthetic polymerPEI-DEG-bis-NPC (PDN) based on polyethylenimine (PEI), and then the properties of thevehicle were characterized by measurement of size distribution, zeta potential andtransmission electron microscopy (TEM). Enhancement of gene transduction byAd/PDN complexes was observed in both CAR-overexpressing cell lines (A549) andCAR-lacking cell lines (MDCK, CHO, LLC), as a result of facilitating binding and celluptake of adenoviral particles by the cationic component. Ad/PDN complexesalso promoted the inhibition of tumor growth in vivo and prolonged the survivaltime of tumor-bearing mice. These data suggest that a combination of viral andnon-viral gene delivery methods may offer a new approach to successful cancer genetherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
